A carregar...

The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer

Aromatase inhibitors (AIs) have become the standard adjuvant therapy of postmenopausal breast cancer survivors. AIs induce a reduction of bioavailable estrogens by inhibiting aromatase, which would be expected to induce alterations in body composition, more extensive than induced by menopause. The o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van Londen, G. J., Perera, S., Vujevich, K., Rastogi, P., Lembersky, B., Brufsky, A., Vogel, V., Greenspan, S. L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3103776/
https://ncbi.nlm.nih.gov/pubmed/21046232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-010-1223-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!